Mosikhin S B, Bezbryazov A V, Moskvin S V
Kazan State Medical Academy, Kazan, Russia.
City Clinical Hospital No. 12, Kazan, Russia.
Vopr Kurortol Fizioter Lech Fiz Kult. 2018;95(3):16-21. doi: 10.17116/kurort201895316.
The prevalence of allergic reactions to the pharmaceutical products and the development of antibiotic resistance limit the provision of the high-quality medical care to the patients presenting with acute bacterial external otitis media (ABEO).
The objective of the present study was to evaluate the effectiveness of the treatment of the patients suffering from ABEO with the application of the new technique based on intravenous blood illumination by low-intensity laser radiation at a wavelength of 445 nm (ILBI-445).
This open comparative clinical study was carried out from April 2017 till June 2017 and included the patients with ABEO who were divided into two groups. The patients of the main group underwent the standard treatment in the combination with low-intensity laser radiation at a wavelength of 445 nm. Those comprising the control group were given the conventional treatment alone. The end point of the study was the complete disappearance of local inflammatory signs in the region of the external auditory canal (EAC) and auricle, the restoration of the volume of the EAC, the absence of complaints estimated based on the visual analogue scale (VAS), and the complete disappearance of symptoms of intoxication. The local signs of inflammation in the region of the EAC and auricle were assessed from the otoscopic picture. The measurement of the volume of the external auditory canal were carried out by filling it with a furacilin solution at a temperature of 36C using a 2 ml syringe. The character of the inflammatory changes in the external auditory canal, the intensity of pain and itching, as well as the degree of hearing loss were estimated at 10 points based on the 10-point visual analogue scale (with 0 points standing for the absence of complaints and 10 points denoting the maximum severity of the complaints). The symptoms of intoxication were determined from the measurements of body temperature.
The combined treatment of the patients with ABEO using ILBI-445 resulted in their earlier recovery in comparison with that achieved by means of the standard therapy. The differences were especially pronounced on the 5th day of treatment. Complaints of pain and the loss of hearing were documented only in the patients of the control group. Itching was a significantly less serious trouble in the patients of the main group than it was in those comprising the control group. The volume of the external auditory canal in the patients of the main group on the 5 day after the onset of the treatment was more than 16.7% greater than in the control one.
The high therapeutic effectiveness and simplicity of the approach employed in the present study taken together with a minimum of contraindications for its application give reason to recommend intravenous blood illumination by low-intensity laser radiation at a wavelength of 445 nm for the treatment of the patients suffering from acute bacterial external otitis.
药品过敏反应的普遍性以及抗生素耐药性的发展限制了为急性细菌性外耳道炎(ABEO)患者提供高质量医疗服务。
本研究的目的是评估应用基于波长为445nm的低强度激光辐射静脉血照射新技术(ILBI-445)治疗ABEO患者的有效性。
本开放性对照临床研究于2017年4月至2017年6月进行,纳入ABEO患者并分为两组。主要组患者接受标准治疗并联合波长为445nm的低强度激光辐射。对照组患者仅接受传统治疗。研究终点为外耳道(EAC)和耳廓区域局部炎症体征完全消失、EAC容积恢复、基于视觉模拟量表(VAS)评估无主诉以及中毒症状完全消失。通过耳镜检查评估EAC和耳廓区域的局部炎症体征。使用2ml注射器将温度为36°C的呋喃西林溶液注入外耳道来测量其容积。根据10分视觉模拟量表(0分表示无主诉,10分表示主诉最严重程度)对外耳道炎症变化特征、疼痛和瘙痒强度以及听力损失程度进行10分评估。通过测量体温确定中毒症状。
与标准治疗相比,使用ILBI-445联合治疗ABEO患者可使其更早康复。差异在治疗第5天尤为明显。仅在对照组患者中记录到疼痛和听力损失主诉。主要组患者的瘙痒问题明显比对照组患者轻。治疗开始后第5天,主要组患者的外耳道容积比对照组大16.7%以上。
本研究采用的方法具有高治疗效果且操作简单,同时应用禁忌证最少,因此有理由推荐使用波长为445nm的低强度激光辐射静脉血照射治疗急性细菌性外耳道炎患者。